TiGenixとは 意味・読み方・使い方

TiGenix (Euronext: TIG) is a late stage biomedical company with corporate headquarters in Leuven, Belgium. It focuses on innovative local treatments for damaged and osteoarthritic joints. TiGenix was founded in 2000 by Prof. Dr. Frank P. Luyten and Gil Beyen as a spin-off from the Katholieke Universiteit Leuven and the Universiteit Gent. TiGenix will establish a new unit of cell expansion at the Campus Chemelot, near Maastricht. The copartnership has also a production facility in Memphis (TN, USA)